Coronavirus: Germany Approves Human Vaccine Trials

Image used for illustrative purposes. (AP Photo/Ted S. Warren)
- Advertisement -

Germany gave the green light for human trials of potential coronavirus vaccines developed by German biotech company BioNTech.

The trial, only the fourth worldwide of a vaccine targeting the virus, will be initially conducted on 200 healthy people, with more subjects, including some at higher risk from the disease, to be included in a second stage, German vaccines regulator the Paul Ehrlich Institut said today.

Tests of the vaccine were also planned in the United States, once regulatory approval for testing on humans had been secured there.

Comments

- Advertisement -